Biomed Myanmar

BioMed Myanmar Co., Ltd is a laboratory and medical instrument distributor which is led by the professional team with a collective experience in clinical and molecular laboratory diagnosis, research area and marketing field. Biomed Myanmar represents the world renown principles like Randox, Boule, Analytik Jena, Snibe, Magnus and Wondfo.

BioMed Myanmar is offering complete technical solutions for molecular diagnosis through supply of top quality instruments, Systems, Hardware & Software, Reagents and Kits to the diagnostic industries interested in molecular technology. We specializes in the distribution of high quality innovative products, technology and services from world leading manufacturers to provide customers latest technology and products from overseas countries backed by excellent services. BioMed Myanmar has marketing arrangements with its principals for marketing of products in Myanmar.

Microscopes are all about optics. At Magnus, we’re all about optics. 

At Magnus, we focus on making Masterclass microscopes. Optics are the heart and soul of a microscope. We pride ourselves for producing some of the best optics in the world.

Inspired by a long association with Japanese manufacturing, Magnus is driven and committed to developing and manufacturing products for today’s scientific and medical community. These products are made in a highly automated plant using cutting edge technologies. We strive to continuously evolve to stay abreast with the speed of change in the technology world.


Shenzhen New Industries Biomedical Engineering Co., Ltd. (Briefed as Snibe Co.,Ltd.) is located in National Biological Industry Park(Shenzhen, China), founded in December 1995. Snibe is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. Snibe has formed a strong team of professionals: Reagents R & D and production center, Instruments R & D and production center, Sales & Marketing center.  


Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou science city, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions since founded in 1992.

Wondfo now has more than 3000 employees and a wide range of products for the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, and so on, widely sold to 140+ countries and regions.


Founded in 1996 in Shenzhen, China, Headway is currently the leading manufacturer & supplier of H. Pylori diagnostic—13C & 14C urea breath test—systems in the world. We are committed to making it easier to pursue good health by leveraging our more than 25 years of innovation in breath tests.

We have 3 R&D Centers,3 Manufacturing Centers in 70,000 m2 Production Area.We are serving in 16 Countries & Regions and 20,000+ Medical Institutions for 300 Million+ People.


Meizhou Cornley

Founded in 1993, Cornley is a national high-tech enterprise specializing in R&D, production and sales of "in-vitro diagnostic apparatus and reagents". After the continuous development and growth, Cornley has now developed into a medical facility manufacturer with more than 300 employees, and has gradually become one of the important forces in the medical facility industry in China.
Cornley is one of the leading professional medical facility suppliers in China and also a national high-tech enterprise. Cornley specializes in the field of clinical examination, with major products such as blood-gas electrolyte analyzer and electrolyte total carbon dioxide analyzer.


Zybio Inc. is a high-tech enterprise specialized in R&D, manufacture, sales and technical services of in vitro diagnostic reagents and equipment, with the headquarter and manufacturing center located in Dadukou District, Chongqing.

Zybio has more than 3,300 employees worldwide, of which R&D personnel account for more than 30% . Nearly 50% of R&D personnel have master's degree or above. The company compared to spend no less than 15% of sales revenue on its research and development.